Glycanostics s.r.o.
Budget
€10 — €0
EP Access
0
accredited persons
Staff
2
0.2 FTE
EU Grants
€1,987,387
Mission & Goals
Glycanostics is developing highly accurate, early-stage tests for detection of 11 types of cancer. The tests are based on detection of glycan changes in blood using Magnetic-based-ELISA. Our CEO, Eva Kovacova, was invited as a speaker to the panel discusstion at the Cancer Mission webinar that will be held on 3rd November 2025.
EU Legislative Interests
Mission cancer initiative
Communication Activities
Panel discussions - our CEO Eva Kovacova was invited as a speaker to the panel discussion at the Cancer Mission Webinar that will be held on 3rd November 2025.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
EIC Scaling Club
Additional Information
Minimal time is dedicated to these activities (attending the events and panel discussions), therefore the costs allocated to these activities are very low.
Commissioner Meetings
No recorded meetings with EU commissioners.